Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NMG
12326
Nouveau Monde Graphite
NMG
$379M
| $51.5K | ﹤0.01% |
+32,378
| New | +$46.6K |
2024 Q4
0 quarters
|
|
12327
PUT
Milestone Pharmaceuticals
MIST
$95.1M
| $51.4K | ﹤0.01% |
+21,800
| New | +$37.4K |
2024 Q4
0 quarters
|
|
12328
CALL
Live Oak Bancshares
LOB
$1.69B
| $51.4K | ﹤0.01% |
1,300
-10,800
| -89% | -$486K |
2022 Q3
9 quarters
|
|
12329
OneMedNet
ONMD
$28.9M
| $51.3K | ﹤0.01% |
3,773
-1,217
| -24% | -$10.9K |
2024 Q3
1 quarter
|
|
12330
Retractable Technologies
RVP
$20.7M
| $51.2K | ﹤0.01% |
74,414
-30,034
| -29% | -$20.6K |
2021 Q3
13 quarters
|
|
|
MAGC
12331
CALL
Roundhill China Magnificent Seven ETF
MAGC
$12.5M
| $51K | ﹤0.01% |
+2,400
| New | +$53.2K |
2024 Q4
0 quarters
|
|
12332
VanEck Preferred Securities ex Financials ETF
PFXF
$2.37B
| $51K | ﹤0.01% |
+2,957
| New | +$53.2K |
2024 Q4
0 quarters
|
|
12333
PUT
Adaptive Biotechnologies
ADPT
$4.29B
| $51K | ﹤0.01% |
8,500
-21,000
| -71% | -$116K |
2020 Q2
18 quarters
|
|
12334
CALL
Petrobras Class A
PBR.A
$139B
| $50.9K | ﹤0.01% |
4,300
+800
| +23% | +$10.3K |
2022 Q1
11 quarters
|
|
|
PRA
12335
CALL
DELISTED
ProAssurance
PRA
| $50.9K | ﹤0.01% |
3,200
+2,900
| +967% | +$46.1K |
2024 Q3
1 quarter
|
|
|
TSVT
12336
CALL
DELISTED
2seventy bio
TSVT
| $50.9K | ﹤0.01% |
17,300
-23,100
| -57% | -$94.7K |
2021 Q4
12 quarters
|
|
|
AEVA
12337
PUT
Aeva Technologies
AEVA
$1.02B
| $50.8K | ﹤0.01% |
+10,700
| New | +$43.3K |
2024 Q4
0 quarters
|
|
12338
PUT
Barings BDC
BBDC
$891M
| $50.7K | ﹤0.01% |
5,300
-1,900
| -26% | -$18.6K |
2023 Q3
5 quarters
|
|
12339
PUT
iShares MSCI Global Gold Miners ETF
RING
$2.33B
| $50.6K | ﹤0.01% |
1,800
+1,000
| +125% | +$31.6K |
2022 Q4
8 quarters
|
|
12340
PUT
XBiotech
XBIT
$65.9M
| $50.6K | ﹤0.01% |
+12,800
| New | +$87.2K |
2024 Q4
0 quarters
|
|
12341
CALL
Clean Energy Fuels
CLNE
$344M
| $50.5K | ﹤0.01% |
20,100
-19,200
| -49% | -$54.5K |
2020 Q1
19 quarters
|
|
|
ORLA
12342
CALL
DELISTED
Orla Mining
ORLA
| $50.4K | ﹤0.01% |
9,100
+800
| +10% | +$3.86K |
2022 Q1
11 quarters
|
|
12343
CALL
LXP Industrial Trust
LXP
$3.59B
| $50.3K | ﹤0.01% |
1,240
-900
| -42% | -$41.7K |
2022 Q4
8 quarters
|
|
|
GATO
12344
PUT
DELISTED
Gatos Silver, Inc.
GATO
| $50.3K | ﹤0.01% |
3,600
-4,100
| -53% | -$66.7K |
2021 Q2
14 quarters
|
|
12345
CALL
1stdibs.com
DIBS
$138M
| $50.3K | ﹤0.01% |
14,200
+9,800
| +223% | +$39.6K |
2022 Q3
9 quarters
|
|
12346
CALL
Usana Health Sciences
USNA
$274M
| $50.2K | ﹤0.01% |
1,400
-2,300
| -62% | -$86K |
2022 Q4
8 quarters
|
|
12347
PUT
CEL-SCI Corp
CVM
$48.2M
| $50.2K | ﹤0.01% |
4,187
+2,554
| +156% | +$58.9K |
2019 Q2
22 quarters
|
|
12348
PUT
RGC Resources
RGCO
$225M
| $50.1K | ﹤0.01% |
2,500
+1,500
| +150% | +$31.1K |
2024 Q3
1 quarter
|
|
12349
PUT
iShares US Energy ETF
IYE
$1.7B
| $50.1K | ﹤0.01% |
1,100
-500
| -31% | -$24K |
2022 Q4
8 quarters
|
|
12350
Amplify BlackSwan Growth & Treasure Core ETF
SWAN
$153M
| $50.1K | ﹤0.01% |
+1,705
| New | +$51.6K |
2024 Q4
0 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.